Editor's Note :

Editor's Note :

There is a possibility of opinions on Wednesday, March 29. We will begin live-blogging at this link at 9:45 a.m.
On Wednesday the court hears oral argument in Turner v. United States. Amy Howe has our preview.
On Wednesday the court also hears oral argument in Honeycutt v. United States. Rory Little has our preview.

Merck & Co. v. Louisiana Wholesale Drug Company, Inc.

Petition granted, judgment vacated and case remanded for further consideration in light of FTC v. Actavis on June 24, 2013

Linked with:

Docket No. Op. Below Argument Opinion Vote Author Term
12-245 3d Cir. N/A N/A N/A N/A OT 2012
 
Share:

Disclosure: Goldstein & Russell, P.C., whose attorneys work for or contribute to this blog in various capacities, serves as co-counsel to the respondents in this case, which is listed without regard to its likelihood of being granted.

Issue: Whether the federal antitrust laws permit a brand-name manufacturer that holds the patent for a drug to enter into a settlement of patent litigation with a prospective generic manufacturer, where the settlement includes a payment from the brand manufacturer to the generic manufacturer but does not exclude competition beyond the scope of the patent.

Plain English Summary:

SCOTUSblog Coverage

Briefs and Documents

Certiorari-stage documents

Term Snapshot
Awards